Dembińska-Kieć A - Search Results

1

beta-Pyridylcarbinol (Ronicol) releases a prostacyclin-like substance into arterial blood of patients with arteriosclerosis obliterans.

Dembińska-Kieć A, Korbut R, Bierón K, Kostka-Trabka E, Gryglewski RJ. Dembińska-Kieć A, et al. Pharmacol Res Commun. 1983 Apr;15(4):377-85. doi: 10.1016/s0031-6989(83)80047-2. Pharmacol Res Commun. 1983. PMID: 6346344

2

Effect of prostacyclin (PGI2) on platelets and fibrinolytic activity in patients with arteriosclerosis obliterans.

Dembińska-Kieć A, Kostka-Trabka E, Zumda A, Byrska-Danek A, Bierón K, Grodzińska L, Kedzior A, Zelazny T. Dembińska-Kieć A, et al. Pharmacol Res Commun. 1982 Jun;14(6):485-98. doi: 10.1016/s0031-6989(82)80039-8. Pharmacol Res Commun. 1982. PMID: 6750655 No abstract available.

3

A potent inhibitor of thromboxane A2 biosynthesis in aggregating human blood platelets.

Gryglewski RJ, Zmuda A, Dembińska-Kieć A, Krecioch E. Gryglewski RJ, et al. Pharmacol Res Commun. 1977 Feb;9(2):109-16. doi: 10.1016/s0031-6989(77)80013-1. Pharmacol Res Commun. 1977. PMID: 866363 No abstract available.

4

Beneficial results of pentoxifylline ('Trental') therapy in arteriosclerosis obliterans: possible mechanism of action.

Kostka-Trabkowa E, Dembińska-Kieć A, Grodzińska L, Bieroń K, Gryglewski RJ. Kostka-Trabkowa E, et al. Curr Med Res Opin. 1985;9(6):407-15. doi: 10.1185/03007998509109612. Curr Med Res Opin. 1985. PMID: 3886306 Clinical Trial.

5

Clinical use of prostacyclin (PGI2) in ischaemic stroke.

Gryglewski RJ, Nowak S, Kostka-Trabka E, Bieroń K, Dembińska-Kieć A, Błaszczyk B, Kuśmiderski J, Markowska E, Szmatoła S. Gryglewski RJ, et al. Pharmacol Res Commun. 1982 Oct;14(9):879-908. doi: 10.1016/s0031-6989(82)80012-x. Pharmacol Res Commun. 1982. PMID: 6757974 No abstract available.

6

Prostacyclin and blood glucose levels in humans and rabbits.

Dembińska-Kieć A, Kostka-Trabka E, Grodzińska L, Zmuda A, Bieroń K, Kedzior A, Ochmański W, Zelazny T. Dembińska-Kieć A, et al. Prostaglandins. 1981 Jan;21(1):113-21. doi: 10.1016/0090-6980(81)90201-x. Prostaglandins. 1981. PMID: 7010454

7

Effect of prostacyclin on fibrinolytic activity in patients with arteriosclerosis obliterans.

Dembinska-Kiec A, Kostka-Trabka E, Gryglewski RJ. Dembinska-Kiec A, et al. Thromb Haemost. 1982 Apr 30;47(2):190. Thromb Haemost. 1982. PMID: 7048622 No abstract available.

8

Effect of corticosteroids on the release of histamine and prostaglandins from fragments of mesentery of immunized guinea pigs.

Dembińska-Kieć A, Grodzińska L, Panczenko B, Gryglewski RJ. Dembińska-Kieć A, et al. Pharmacol Res Commun. 1978 Feb;10(2):153-60. doi: 10.1016/s0031-6989(78)80073-3. Pharmacol Res Commun. 1978. PMID: 77533 No abstract available.

9

A possible role of thromboxane A2 (TXA2) and prostacyclin (PGI2) in circulation.

Gryglewski RJ, Dembínska-Kieć A, Korbut R. Gryglewski RJ, et al. Acta Biol Med Ger. 1978;37(5-6):715-23. Acta Biol Med Ger. 1978. PMID: 369254

10

Interaction between prostacyclin and molsidomine in blood cells and plasma.

Gryglewski RJ, Bieroń K, Dembińska-Kieć A, Kostka-Trabka E, Zembowicz A. Gryglewski RJ, et al. Adv Prostaglandin Thromboxane Leukot Res. 1991;21B:655-8. Adv Prostaglandin Thromboxane Leukot Res. 1991. PMID: 1825393 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

237 results

Search Page